Pharma
Costco now offers GLP-1s, but that won’t have a major market shift, experts say
The direct-to-consumer GLP-1 market continues to grow.
Drug Affordability
Stay updated on Drug Affordability trends and industry impact. Healthcare Brew provides the latest news and professional analysis on Drug Affordability's role in Drug Pricing, Access, & Affordability and Pharma.
Pharma
Pharma execs share their projections for the industry in 2025
From GLP-1s to AI, leaders share their thoughts.
Pharma
Medicaid spending on GLP-1s has skyrocketed since 2019, study finds
Spending rose more than 500% in the last five years, KFF researchers found.
Pharma
How GoodRx’s low-cost Humira biosimilar could affect the market
GoodRx is partnering with Boehringer Ingelheim to offer a 92% discount on Humira.
Pharma
GSK to join AstraZeneca, Boehringer Ingelheim in capping out-of-pocket inhaler costs
The cap is set to take effect by January 1, 2025.
Pharma
AstraZeneca to cap out-of-pocket inhaler costs at $35
The cap will take effect June 1 for patients with commercial insurance, as well as uninsured and underinsured individuals.
Pharma
Boehringer Ingelheim to cap monthly out-of-pocket inhaler costs at $35
The move follows a congressional probe into inhaler costs.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
